1998-2000
|
INTAS-Coordination representative, Bologna, Minsk
|
|
1998-1999
|
Coorperation Bayer AG
|
|
1998-1999
|
Cooperation DuMont
|
|
1996-2005
|
Cooperation Hans-Knöll-Institute
|
|
1996-1999
|
Henkel KGaA
|
|
1996-1999
|
Deutsche Forschungsgemeinschaft
|
SCHM1012-1
|
1997-1999
|
EVOTEC OAI, Hamburg
|
|
1995-1999
|
DAAD/SI Prof. Anders Hallberg, Uppsala Universitet, SE
|
|
1997-2002
|
Fonds der Chemischen Industrie
|
|
2002-2007
|
Schwerpunktprogramm DFG Alzheimer SPP 1085
|
SCHM1012-3
|
2003-2004
|
Novartis Pharma AG, Basel: NMR Probes
|
|
2004-2007
|
EU Framework 6: integrated project: APOPIS
|
Verum Foundation
|
2004-2006
|
MSD Germany
|
|
2004-
|
Roche, Basel: CNS
|
|
2005-2007
|
Schering AG, Berlin: CNS
|
|
2005-2007
|
BMBF: TSE – Neurodegenerative Diseases
|
Prion Protein
|
2005-2007
|
DAAD
|
|
2007-
|
BMBF Kompetenznetz Degenerative Demenzen KNDD (opens in new tab)
|
BMBF Information on AD Research (opens in new tab)
|
2008-2011
|
EU Framework 7: Neuro.GSK3
|
|
2010-2013
|
BMBF MINDE – Molecular Diagnosis of Neurodegenerative Diseases in the Eye
|
|
2011-
|
DFG GrK – Molecular and Cellular Reactions of Ionizing Radiation
|
|
2012
|
Breuer-Stiftung – Research Award on Alzheimer Disease
|
|